Scholarlink

Objective <p>To assess the feasibility and safety of right heart catheterization (RHC) via the cubital vein.</p> Methods <p>This retrospective-prospective cohort study included 93 patients (January 2020–June 2023) in the retrospective phase, with 48 undergoing cubital vein RHC (R-CV) and 45 femoral vein RHC (R-FV). A prospective phase (July 2023–October 2024) enrolled 60 patients, each undergoing both approaches. Subgroup analysis divided patients by right ventricular end-diastolic diameter (≥ 3.80&#xa0;cm vs. &lt;3.80&#xa0;cm).</p> Results <p>R-CV showed fewer complications (8.89% vs. 0%, <i>p</i> = 0.028) and shorter fluoroscopy time (178.27 ± 43.27&#xa0;s vs. 210.76 ± 54.80&#xa0;s, <i>p</i> = 0.002) than R-FV. In patients with right ventricular dilation (≥ 3.80&#xa0;cm), cubital vein RHC reduced fluoroscopy time compared to femoral vein RHC (<i>p</i> &lt; 0.001).</p> Conclusion <p>Cubital vein RHC is safe, efficient, and especially advantageous for patients with enlarged right ventricles, warranting wider adoption.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Feasibility and safety of right heart catheterization via median cubital vein in patients with pulmonary hypertension

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月27日

查看全文
  • Yuxing Lai,
  • Lingyun He,
  • Han Cai,
  • Wei Zhou,
  • Jinzi Su,
  • Pingping Wu,
  • Zhoufei Fang

摘要

Objective

To assess the feasibility and safety of right heart catheterization (RHC) via the cubital vein.

Methods

This retrospective-prospective cohort study included 93 patients (January 2020–June 2023) in the retrospective phase, with 48 undergoing cubital vein RHC (R-CV) and 45 femoral vein RHC (R-FV). A prospective phase (July 2023–October 2024) enrolled 60 patients, each undergoing both approaches. Subgroup analysis divided patients by right ventricular end-diastolic diameter (≥ 3.80 cm vs. <3.80 cm).

Results

R-CV showed fewer complications (8.89% vs. 0%, p = 0.028) and shorter fluoroscopy time (178.27 ± 43.27 s vs. 210.76 ± 54.80 s, p = 0.002) than R-FV. In patients with right ventricular dilation (≥ 3.80 cm), cubital vein RHC reduced fluoroscopy time compared to femoral vein RHC (p < 0.001).

Conclusion

Cubital vein RHC is safe, efficient, and especially advantageous for patients with enlarged right ventricles, warranting wider adoption.